inobrodib
cellcentric
['inobrodib', 'pioneer']
#aacr23 1.30-5pm: section 46, board 24. inobrodib, pioneering p300/cbp oral inhibitor, treating haem malignancies. poster: 
Inobrodib (CCS1477): first-in-class p300/CBP small molecule inhibitor drug, to treat specific cancers.